AMZN
Amazon.com, Inc.
AMZN has the edge over ELA overall, supported by stronger modeled upside and lower modeled downside.
ELA
Envela Corporation
ELA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ELA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Healthy | |
| Strong |
ELA's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ELA in the historical PE scenario, which offers more potential upside but is not a forecast.
ELA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $10.14 | -2.4% |
| Current | 12x | $10.39 | — |
| Fair | 18x | $15.50 | +49% |
| Forward | 19x | $10.39 | — |
| Expensive | 30x | $25.09 | +141% |
Historical ranges are pointers, not guarantees.
ELA's PE is in its cheap range at 12x. Analysts expect earnings to fall, which would put today's price at 19x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over ELA on the outlook, with more favorable earnings and revenue expectations.
ELA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect ELA's earnings and revenue to decline, with profitability weakening.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ELA on earnings, with more consistent year-over-year improvement.
ELA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | -35% |
| Q2 2026 | $0.85 | +150% |
| Q1 2026 | $0.80 | +176% |
| Q4 2025 | $0.56 | +115% |
| Q3 2025 | $0.41 | +64% |
| Q2 2025 | $0.34 | +36% |
| Q1 2025 | $0.29 | +16% |
| Q4 2024 | $0.26 | -3.7% |
| Q3 2024 | $0.25 | -42% |
ELA earned $0.85 per share over the past year, up 150% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ELA on profitability, with a higher operating margin.
ELA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $56.8M | +3.5% |
| Q1 2026 | $98.4M | +104% |
| Q4 2025 | $80.5M | +67% |
| Q3 2025 | $57.4M | +22% |
| Q2 2025 | $54.9M | +21% |
| Q1 2025 | $48.3M | +21% |
| Q4 2024 | $48.3M | +32% |
| Q3 2024 | $46.9M | +29% |
ELA has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9% | +3.1 points |
| Q1 2026 | 11% | +4.9 points |
| Q4 2025 | 9.4% | +5.4 points |
| Q3 2025 | 7.3% | +3 points |
| Q2 2025 | 5.9% | +1.7 points |
| Q1 2025 | 6.5% | +0.6 points |
| Q4 2024 | 3.9% | -0.4 points |
| Q3 2024 | 4.3% | -1.1 points |
ELA's operating margin was 9% last quarter, up 3.1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ELA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5M | +137% |
| Q1 2026 | $20.6M | +2658% |
| Q4 2025 | -$3.7M | -215% |
| Q3 2025 | $2.2M | +51% |
| Q2 2025 | $2.1M | +$3.4M |
| Q1 2025 | $746.6K | -78% |
| Q4 2024 | $3.2M | +91% |
| Q3 2024 | $1.5M | +172% |
ELA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ELA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.1% | -28.5K shares |
| 3 years | -3.6% | -968K shares |
| 5 years | -3.6% | -976K shares |
| Available history | -3.6% | -961K shares |
ELA has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $67,582 |
| Q2 2025 | $118,700 |
| Q1 2025 | $2,626 |
| Q4 2024 | $64,779 |
| Q3 2024 | $728,510 |
| Q2 2024 | $715,339 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ELA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
ELA has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ELA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.8 | Oversold |
| Stochastic | 1.6 | Oversold |
ELA's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ELA PE vs Consumer Cyclical Sector
| Metric | ELA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 20 | 47 | 27 pts below |
ELA has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over ELA on trend strength, trading above more of its moving averages.
ELA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 10% below |
| 20 week MA | $15.3 | 32% below |
| 50 week MA | $16.6 | 37% below |
| 100 week MA | $11.8 | 12% below |
| 200 week MA | $8.64 | 20% above |
ELA has fallen below most of its moving averages, though it's still 20% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over ELA on returns for 2026, with the stronger performance.
ELA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.37 | $5.01 | +266% |
| 2021 | $5.01 | $4.10 | -18% |
| 2022 | $4.10 | $5.29 | +29% |
| 2023 | $5.29 | $4.86 | -8.1% |
| 2024 | $4.86 | $7.15 | +47% |
| 2025 | $7.15 | $12.5 | +75% |
| 2026 YTD | $12.5 | $10.4 | -17% |
ELA has finished higher in four of the last six years, two of them by more than 50%. It's down 17% so far in 2026.